EU Gram-Negative Infection Market, Market Segmented by Type of Infection (Surgical Site Infections, Pneumonia, Urinary Tract Infections, Bloodstream Infections, and Meningitis), and by Treatment (Carbapenems, Colistin, Tigecyclin, Sulbactam, Doxycycline, and Rifampin) - Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138176
- Pages: 200
-
Format:
Report Overview
The EU Gram-Negative Infection Market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli (GNB). An upsurge in antibiotic resistance is mainly due to indiscriminate and inappropriate use of antibiotics and a marked decline in the development of efficacious antimicrobial agents
Market Drivers
The rising research and development activities coupled with increasing investments are driving the Europe Gram-Negative infection market
1. EU Gram-Negative Infection Market Overview
A. Market Size
2. EU Gram-Negative Infection Market Growth Drivers.
A. The rising research and development activities coupled with increasing investments
3. EU Gram-Negative Infection Market Segmentation
A. By Type of Infections
I. Surgical site infection
II. Pneumonia
III. Urinary Tract Infection
IV. Blood Stream Infection
V. Meningitis
B. By Treatment
I. Carbapenems
II. Colistin
III. Tigecyclin
IV. Sulbactam
V. Doxycycline
VI. Rifampin
4. EU Gram-Negative Infection Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Baxter International Inc, Company overview, Product & Services, Strategies & Financials
B. Pfizer Inc., Company overview, Product & Services, Strategies & Financials
C. Shionogi & Co. Ltd., Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
